Market Place
Sourcing Support
Galera tanks after FDA declines to approve avasopasem for patients with cancer
10 Aug 2023 //
REUTERS
Galera Announces Priority Review of Avasopasem NDA for Oral Mucositis
15 Feb 2023 //
GLOBENEWSWIRE
Galera Submits New Drug Application for Avasopasem for Severe Oral Mucositis
12 Dec 2022 //
GLOBENEWSWIRE
Galera`s Oral Presentation at 2022 ASCO on PIII ROMAN Trial of Avasopasem
26 May 2022 //
GLOBENEWSWIRE
Galera shares rise over 100% as phase 3 flop deemed an error
15 Dec 2021 //
FIERCEBIOTECH
Galera shares slide as radiotherapy complication drug fails
20 Oct 2021 //
FIERCEBIOTECH
Galera Announces Completion of Enrollment in Phase 3 Trial of Avasopasem
28 Jun 2021 //
GLOBENEWSWIRE
Galera Therapeutics Announces beginning of Clinical Trial of GC4419 for COVID-19
16 Sep 2020 //
BIOSPACE
Galera Therapeutics Announces New Data from the Phase 2b Trial
13 May 2020 //
GLOBENEWSWIRE
Galera`s Announces Presentation of Avasopasem Manganese Data at ASCO 2020
30 Apr 2020 //
GLOBENEWSWIRE
Galera`s Announces Avasopasem Manganese (GC4419) Maintained Anti-Cancer Benefit
27 Feb 2020 //
GLOBENEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.